Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prevention of Cardiovascular Relapses by L-Arginine Oral Administration in Patients With CAD and IGT and/or Insulin Resistance.

NCT00408577 is registered in ClinicalTrials.gov with IRCCS San Raffaele as lead sponsor.

NCT NCT00408577
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00408577 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prevention of Cardiovascular Relapses by L-Arginine Oral Administration in Patients With CAD and IGT and/or Insulin Resistance.
Lead sponsor
IRCCS San Raffaele
Phase
Phase 3
Overall status
Completed
Start date
November 30, 2004
Completion date
November 30, 2006
Enrollment
150
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiovascular disease